Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04121871
Other study ID # Oral Fungal Infection
Secondary ID
Status Completed
Phase
First received
Last updated
Start date November 15, 2019
Est. completion date February 29, 2020

Study information

Verified date October 2020
Source Islamia University of Bahawalpur
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Candida auris is emerging fungal opportunistic pathogen in developing countries. Much studies has been conducted on Candida albicans. there was a dire need to investigate this alarming threat. Our hypothesis is that by recording the patients diagnosed with oropharygneal candidiasis and collecting clinical swab samples from these patients will be fruitful if microbiological isolation, identification and molecular characterization will be done. So this is the first study on C. auris in south punjab, Pakistan. Aim of this study is to collect epidemiological data of C. auris.


Recruitment information / eligibility

Status Completed
Enrollment 384
Est. completion date February 29, 2020
Est. primary completion date February 29, 2020
Accepts healthy volunteers No
Gender All
Age group N/A to 100 Years
Eligibility Inclusion Criteria: - Pre-diagnosed Patients of both gender from pre-selected localities Exclusion Criteria: - Healthy individuals or individuals having no oral fungal infection individuals above 100 years of age

Study Design


Related Conditions & MeSH terms


Intervention

Other:
No intervention
Not required

Locations

Country Name City State
Pakistan Bahawal Victoria Hospital Bahawalpur Bahawalpur Punjab
Pakistan Civil Hospital Jhangi Wala Road Bahawalpur Bahawalpur Punjab

Sponsors (1)

Lead Sponsor Collaborator
Islamia University of Bahawalpur

Country where clinical trial is conducted

Pakistan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Prevalence of C. auris patients from selected localities will be recorded along with total patients in that category, prevalence will be calculated on the record collected from specified duration of study From November 15, 2019 to February 29, 2020
Primary Seasonality of C. auris infection Number of patients recorded during different months will be the source of calculation of seasonality index of the C. auris infection From November 15, 2019 to February 29, 2020
Primary Drug susceptibility Antifungal drug discs will be used for assessing the antfungal drugs susceptibility From November 15, 2019 to February 29, 2020